Evidence map›Paper›PMID 14604435›Full record

ArticleBMC biotechnology2003

Expressing functional siRNAs in mammalian cells using convergent transcription.

Nham Tran, Murray J Cairns, Ian W Dawes, Greg M Arndt

Open access · goldAbstract read
In one paragraph

Article in BMC biotechnology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. RNA interference: its use as antiviral therapy.Handbook of experimental pharmacology · 2006
    Review
  18. A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs.Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research · 2005
    Article
  19. Frog Prince transposon-based RNAi vectors mediate efficient gene knockdown in human cells.Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research · 2005
    Article
  20. Design and application of a versatile expression vector for RNAi in mammalian cells.Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nham TranJohnson and Johnson Research Pty Ltd, 1 Central Ave, Australian Technology Park, Eveleigh, NSW 1430, Australia. nham@nucleics.com
Murray J Cairns
Ian W Dawes
Greg M Arndt
Johnson & Johnson (Australia) · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of small interfering RNAs (siRNAs) as genetic inhibitors of gene expression has been shown to be an effective way of studying gene function in mammalian cells. Recently, different DNA vectors for expression of small hairpin RNAs (shRNAs) or co-expression of sense and antisense RNAs have been developed that direct siRNA-mediated gene silencing. One expression cassette design that has been used to express long sense and antisense RNAs in non-mammalian cell types is symmetric transcription using convergent promoters. However, convergent transcription as a way to generate functional siRNAs in mammalian cells has not been reported. This vector design permits the generation of expression constructs containing no repeat sequences, but capable of inducing RNA interference (RNAi)-mediated gene silencing.

resultsWith the aim of simplifying the construction of RNAi expression vectors, we report on the production and application of a novel convergent promoter cassette capable of expressing sense and antisense RNAs, that form double-stranded RNA, and mediate gene silencing in mammalian cells. We use this cassette to inhibit the expression of both the EGFP transgene and the endogenous TP53 gene. The gene silencing effect is Dicer-dependent and the level of gene inactivation achieved is comparable to that produced with synthetic siRNA. Furthermore, this expression system can be used for both short and long-term control of specific gene expression in mammalian cells.

conclusionThe experiments performed in this study demonstrate that convergent transcription can be used in mammalian cells to invoke gene-specific silencing via RNAi. This method provides an alternative to expression of shRNAs and co-expression of sense and antisense RNAs from independent cassettes or a divergent promoter. The main advantage of the present vector design is the potential to produce a functional siRNA expression cassette with no repeat sequences. Furthermore, the cassette design reported is ideal for both routine use in controlling specific gene expression and construction of randomised RNAi expression libraries for use in unbiased forward genetic selections.

Indexed as

RNA InterferenceCell LineCell Line, TumorGene ExpressionGenetic VectorsGreen Fluorescent ProteinsHumansLuminescent ProteinsOligonucleotidesOligonucleotides, AntisensePromoter Regions, GeneticRNA, Small InterferingRNA, Small NuclearTranscription, GeneticTransfectionTumor Suppressor Protein p53Green Fluorescent ProteinsLuminescent ProteinsOligonucleotidesOligonucleotides, AntisenseRNA, Small InterferingRNA, Small NuclearTumor Suppressor Protein p53U6 small nuclear RNA

Identifiers

PMID14604435
PMCPMC280659
OpenAlexW1957468555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.